Skip to content
Biodatica
Start free

Investigator

Jeffrey Wallace Tyner

OREGON HEALTH & SCIENCE UNIVERSITY · funded by NCI, NIGMS

Companies
1

Resolved onto their grants.

Grants
10

Federal awards on file.

Non-dilutive funding
$6.1M

Summed across those awards.

First award
Aug 1, 1997

Latest Jun 15, 2022.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. U01

    Proteogenomic characterization of early and late resistance mechanisms in acute myeloid leukemia

    $1.2M

    Jun 15, 2022NCIOREGON HEALTH & SCIENCE UNIVERSITYNIH RePORTER · 11113819 (opens the source filing in a new tab)

  2. U01

    Proteogenomic characterization of early and late resistance mechanisms in acute myeloid leukemia

    $1.2M

    Jun 15, 2022NCIOREGON HEALTH & SCIENCE UNIVERSITYNIH RePORTER · 11330523 (opens the source filing in a new tab)

  3. T32

    Program in Biomedical Sciences

    $534k

    Jul 1, 2021NIGMSOREGON HEALTH & SCIENCE UNIVERSITYNIH RePORTER · 11064779 (opens the source filing in a new tab)

  4. T32

    Program in Biomedical Sciences

    $541k

    Jul 1, 2021NIGMSOREGON HEALTH & SCIENCE UNIVERSITYNIH RePORTER · 11333422 (opens the source filing in a new tab)

  5. R01

    Mechanisms of venetoclax combination activity in acute myeloid leukemia

    $352k

    Jun 2, 2021NCIOREGON HEALTH & SCIENCE UNIVERSITYNIH RePORTER · 11099796 (opens the source filing in a new tab)

  6. R01

    Mechanisms of venetoclax combination activity in acute myeloid leukemia

    $393k

    Jun 2, 2021NCIOREGON HEALTH & SCIENCE UNIVERSITYNIH RePORTER · 11363931 (opens the source filing in a new tab)

  7. U54

    Trajectory and Architecture of Tumor Intrinsic Drug Resistance in AML

    $304k

    Sep 30, 2017NCIOREGON HEALTH & SCIENCE UNIVERSITYNIH RePORTER · 11180346 (opens the source filing in a new tab)

  8. U54

    Core A: Administrative Core

    $266k

    Sep 30, 2017NCIOREGON HEALTH & SCIENCE UNIVERSITYNIH RePORTER · 11180338 (opens the source filing in a new tab)

  9. U54

    Architecture and Trajectory of Acquired Resistance to Therapy in AML

    $1.3M

    Sep 30, 2017NCIOREGON HEALTH & SCIENCE UNIVERSITYNIH RePORTER · 11180337 (opens the source filing in a new tab)

  10. P30

    Translational Oncology Research Program

    $57k

    Aug 1, 1997NCIOREGON HEALTH & SCIENCE UNIVERSITYNIH RePORTER · 11170755 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources